Leading experts shared new data reinforcing TriClip™ TEER’s safety and effectiveness. The session emphasized early intervention benefits, featuring a live-in-a-box case of successful mixed TR treatment. In the mitral segment, polling showed a shift toward treating more RESHAPE-like patients, highlighting the need for timely referrals. Strong engagement showed momentum for earlier TEER.